one hundred thirteen patients were prospectively randomized to receive 12 cycles of either cvpp ( ccnu , vinblastine , procarbazine , and prednisone ) , abos ( bleomycin , vincristine [ oncovin ; lilly , indianapolis ] , doxorubicin [ adriamycin , adria laboratories , columbus , ohio ] , and streptozotocin ) , or alternating cycles of cvpp and abos .
C0042670
vinblastine
C0056634
cvpp